0001882464 2025-01-01 2025-03-31 0001882464 MSSA:UnitsEachConsistingOfOneOrdinaryShare0.001ParValueOneRedeemableWarrantAndOneRightMember 2025-01-01 2025-03-31 0001882464 MSSA:OrdinaryShares0.001ParValueMember 2025-01-01 2025-03-31 0001882464 MSSA:RedeemableWarrantsEachWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember 2025-01-01 2025-03-31 0001882464 MSSA:RightsToReceiveOnetenth110thOfOneOrdinaryShareMember 2025-01-01 2025-03-31 0001882464 2025-03-31 0001882464 2024-12-31 0001882464 2024-01-01 2024-03-31 0001882464 MSSA:OrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-03-31 0001882464 MSSA:OrdinarySharesSubjectToPossibleRedemptionMember 2024-01-01 2024-03-31 0001882464 MSSA:OrdinarySharesNotSubjectToPossibleRedemptionMember 2025-01-01 2025-03-31 0001882464 MSSA:OrdinarySharesNotSubjectToPossibleRedemptionMember 2024-01-01 2024-03-31 0001882464 us-gaap:CommonStockMember 2024-12-31 0001882464 us-gaap:RetainedEarningsMember 2024-12-31 0001882464 us-gaap:CommonStockMember 2023-12-31 0001882464 us-gaap:RetainedEarningsMember 2023-12-31 0001882464 2023-12-31 0001882464 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001882464 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001882464 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001882464 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001882464 us-gaap:CommonStockMember 2025-03-31 0001882464 us-gaap:RetainedEarningsMember 2025-03-31 0001882464 us-gaap:CommonStockMember 2024-03-31 0001882464 us-gaap:RetainedEarningsMember 2024-03-31 0001882464 2024-03-31 0001882464 us-gaap:IPOMember 2022-04-05 2022-04-05 0001882464 MSSA:UnderwritersMember us-gaap:OverAllotmentOptionMember 2022-04-05 2022-04-05 0001882464 MSSA:UnderwritersMember us-gaap:OverAllotmentOptionMember 2022-04-05 0001882464 2022-04-05 2022-04-05 0001882464 us-gaap:IPOMember 2022-04-05 0001882464 us-gaap:OverAllotmentOptionMember 2022-04-05 2022-04-05 0001882464 us-gaap:OverAllotmentOptionMember 2022-04-05 0001882464 MSSA:FounderSharesMember MSSA:SponsorMember 2021-09-01 2021-09-30 0001882464 MSSA:FounderSharesMember MSSA:SponsorMember 2021-09-30 0001882464 us-gaap:IPOMember 2021-04-05 0001882464 us-gaap:IPOMember 2021-04-05 2021-04-05 0001882464 2022-08-16 2022-08-16 0001882464 2023-07-13 2023-07-13 0001882464 MSSA:NonRedeemableSharesMember 2025-01-01 2025-03-31 0001882464 MSSA:RedeemableSharesMember 2025-01-01 2025-03-31 0001882464 MSSA:NonRedeemableSharesMember 2024-01-01 2024-03-31 0001882464 MSSA:RedeemableSharesMember 2024-01-01 2024-03-31 0001882464 2023-01-26 2023-01-26 0001882464 2023-10-30 2023-10-30 0001882464 2023-10-30 0001882464 us-gaap:PrivatePlacementMember 2022-04-05 2022-04-05 0001882464 us-gaap:PrivatePlacementMember 2022-04-05 0001882464 MSSA:SponsorMember 2022-04-05 2022-04-05 0001882464 MSSA:FounderSharesMember MSSA:SponsorMember 2021-07-05 2021-07-05 0001882464 srt:MaximumMember MSSA:FounderSharesMember MSSA:SponsorMember 2021-07-05 2021-07-05 0001882464 MSSA:FounderSharesMember MSSA:SponsorMember 2021-07-05 0001882464 srt:MaximumMember MSSA:FounderSharesMember MSSA:SponsorMember 2021-09-01 2021-09-30 0001882464 us-gaap:RelatedPartyMember MSSA:AdministrativeServicesAgreementMember 2022-04-05 0001882464 us-gaap:RelatedPartyMember MSSA:AdministrativeServicesAgreementMember 2025-01-01 2025-03-31 0001882464 us-gaap:RelatedPartyMember MSSA:AdministrativeServicesAgreementMember 2024-01-01 2024-12-31 0001882464 us-gaap:RelatedPartyMember MSSA:AdministrativeServicesAgreementMember 2025-03-31 0001882464 us-gaap:RelatedPartyMember MSSA:AdministrativeServicesAgreementMember 2024-12-31 0001882464 MSSA:SponsorMember 2021-06-15 0001882464 MSSA:MStarManagementCorpMember 2023-01-03 0001882464 MSSA:SponsorMember 2023-01-03 0001882464 MSSA:MStarManagementCorpMember 2023-04-18 0001882464 srt:MaximumMember MSSA:MStarManagementCorpMember 2023-04-18 0001882464 MSSA:MStarManagementCorpMember 2023-12-22 0001882464 srt:MaximumMember MSSA:MStarManagementCorpMember 2023-12-22 0001882464 2023-01-04 2023-01-04 0001882464 2023-01-04 0001882464 2023-02-01 2023-02-28 0001882464 srt:MinimumMember 2023-11-01 2023-11-30 0001882464 2023-11-01 2023-11-30 0001882464 2023-11-30 0001882464 us-gaap:RelatedPartyMember 2025-03-31 0001882464 us-gaap:RelatedPartyMember 2024-12-31 0001882464 MSSA:SponsorMember 2025-03-31 0001882464 MSSA:SponsorMember 2024-12-31 0001882464 srt:MaximumMember MSSA:LadenburgThalmannMember us-gaap:OverAllotmentOptionMember 2021-08-10 2021-08-10 0001882464 us-gaap:IPOMember 2025-01-01 2025-03-31 0001882464 us-gaap:ServiceMember 2024-11-01 2024-11-30 0001882464 us-gaap:ServiceMember 2025-01-01 2025-03-31 0001882464 us-gaap:ServiceMember 2024-01-01 2024-12-31 0001882464 srt:MinimumMember 2023-01-01 2023-12-31 0001882464 srt:MaximumMember 2024-02-05 2024-02-05 0001882464 2024-02-05 2024-02-05 0001882464 2022-04-05 0001882464 us-gaap:OverAllotmentOptionMember 2025-01-01 2025-03-31 0001882464 us-gaap:WarrantMember 2025-03-31 0001882464 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001882464 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:WarrantMember 2025-03-31 0001882464 MSSA:InitialBusinessCombinationMember us-gaap:WarrantMember 2025-03-31 0001882464 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0001882464 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0001882464 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0001882464 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001882464 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001882464 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001882464 2025-04-02 0001882464 MSSA:SponsorMember us-gaap:SubsequentEventMember 2025-04-01 2025-04-30 0001882464 MSSA:SponsorMember us-gaap:SubsequentEventMember 2025-04-30 iso4217:USD shares iso4217:USD shares pure false Q1 --12-31 0001882464

10-Q true 2025-03-31 2025 false 001-41344 METAL SKY STAR ACQUISITION CORPORATION E9 00-0000000 221 River Street 9th Floor Hoboken NJ 07030 (332) 237-6141 Not Applicable Units, each consisting of one Ordinary Share, $0.001 par value, one redeemable warrant, and one right MSSUF Ordinary Shares, $0.001 par value MSSAF Redeemable warrants, each warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share MSSWF Rights to receive one-tenth (1/10th) of one Ordinary Share MSSRF No Yes Non-accelerated Filer true true false true 3757451 0.001

67344

6325

67344

6325

6898161

6677519

6898161

6677519

6965505

6683844

455455

400286

1310823

1081153

2972403

2822403

4738681

4303842

2875000 2875000

2875000

7613681

7178842

552451

12.49

12.09

6898161

6677519

0.001

50000000

3205000

552451

3205

-7549542

-7175722

-7546337

-7172517

6965505

6683844

223820 161819

223820

161819

-223820

-161819

46244

301779

24398

157060

70642

458839

-153178

297020

-153178

297020

552451

3202416

0.30

0.14

3205000

-0.10

-0.05

3205000

3205

-7175722

-7172517

-150000 -150000 -70642 -70642

-153178

3205000

3205

-7549542

-7546337

3205000

3205

-5772847

-5769642

3205000

3205

-5772847

-5769642

-150000 -150000 -458839 -458839

297020

3205000

3205

-6084666

-6081461

3205000

3205

-6084666

-6081461

-153178

297020

46244

301779

24398

157060

25287

1875

86306

600

229670

54000

55169

106544

150000

250000

-150000

-250000

150000

250000

150000

250000

220642 608839

Note 1 – Description of Organization and Business Operations Organization and General Metal Sky Star Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on May 5, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). The Company’s efforts in identifying prospective target businesses will not be limited to a particular geographic region. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company’s sponsor is M-Star Management Corporation, a British Virgin Islands incorporated company (the “Sponsor”). At March 31, 2025, the Company had not yet commenced any operations. All activity through March 31, 2025 relates to the Company’s formation and the proposed initial public offering (“IPO”) and its Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year-end. The Company initially had 9 months from the closing of the IPO (or up to 28 months from the closing of our initial public offering if we extend the period of time to consummate a business combination) to consummate a Business Combination (the “Combination Period”). If the Company fails to consummate a Business Combination within the Combination Period, it will trigger its automatic winding up, liquidation and subsequent dissolution pursuant to the terms of the Company’s amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. Accordingly, no vote would be required from the Company’s shareholders to commence such a voluntary winding up, liquidation and subsequent dissolution. On April 5, 2022, the Company consummated the IPO of 11,500,000 units which includes an additional <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_z2iDTnUswAo6" title="Number of shares issued">1,500,000 units as a result of the underwriters’ fully exercise of the over-allotment, at $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zFNqwEaMVc9a" title="Price per share">10.00 per Unit, generating gross proceeds of $115,000,000, which is described in Note 3. On October 30, 2023 during the Extraordinary General Meeting, the shareholders approved an amendment to the company’s Amended and Restated Memorandum and Articles of Association to extend the date up to six (6) months which the company must consummate a business combination to August 5, 2024. On August 6, 2024, the Company filed the preliminary proxy statements to SEC, which had proposed to amend the memorandum and articles of association of the Company to extend the date of consummate a business combination to April 5, 2025. On March 17, 2025, the Company filed a definitive proxy statement with the SEC in connection with calling on an Extraordinary General Meeting to be held on April 2, 2025, which had proposed to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination from April 5, 2025 to January 5, 2026. The Trust Account As of April 5, 2022, a total of $115,682,250 of the net proceeds from the IPO and the private placement transaction completed with the Sponsor, was deposited in a trust account established for the benefit of the Company’s public shareholders with Wilmington Trust, National Association acting as trustee. As of March 31, 2025, and December 31, 2024, the Company had $6,898,161 and $6,677,519 held in the Wilmington Trust account, respectively. The funds held in the Trust Account will be invested only in United States government treasury bills, bonds or notes having a maturity of 180 days or less, or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act and that invest solely in United States government treasuries. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income or other tax obligations, the proceeds will not be released from the Trust Account until the earlier of the completion of a Business Combination or the Company’s liquidation. Liquidity On April 5, 2022, the Company consummated the IPO of 11,500,000 units (including the exercise of the over-allotment option by the underwriters in the IPO) at $10.00 per unit (the “Public Units’), generating gross proceeds of $115,000,000. Each Unit consists of one ordinary share, one redeemable warrant to purchase one ordinary share (each a “Warrant”, and, collectively, the “Warrants”), and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of a Business Combination. Simultaneously with the consummation of the IPO, the Company sold to its Sponsor <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zWtvoUjc2Qn1" title="Number of shares issued">330,000 units at $10.00 per unit in a private placement generating total gross proceeds of $3,300,000 which is described in Note 4. Offering costs amounted to $5,704,741 consisting of $<span id="xdx_90E_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_pp0p0_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSlonJbZFZW6" title="Underwriting fees">2,300,000 of underwriting fees, $2,875,000 of deferred underwriting fees, and $529,741 of other offering costs. Except for $25,000 of subscription of ordinary shares (as defined in Note 5), the Company received net proceeds of $115,682,250 from the IPO and the private placement. As of March 31, 2025, and December 31, 2024, the Company had $nil of cash held in escrow, $4,671,337 and $4,297,517 of working deficit, respectively. In September 2021, the Company repurchased <span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodShares_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zKRR15dzMyB" title="Number of founder shares repurchased">1,437,500 of founder shares for $<span id="xdx_90C_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ztR8Z4J7MBa5" title="Repurchased founder shares value">25,000. In September 2021, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zZ47Yc0YtMpc" title="Number of founder shares issued">2,875,000 of founder shares for $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zgeZknS9P1ue" title="Issued founder shares value">25,000 which include an aggregate of up to <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zUPwc1vAL2L7" title="Ordinary shares subject to forfeiture">375,000 ordinary shares subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment is not exercised in full or in part, so that the Sponsor will collectively own <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zkCRqUiqxdNc" title="Ownership percentage">20% of the Company’s issued and outstanding ordinary shares after the IPO. On April 5, 2022, the underwriter exercised the over-allotment option in full, accordingly, no Founder Shares are subject to forfeiture. Going Concern and Management Liquidity Plan As of March 31, 2025, the Company had a $nil in cash and a working capital deficit of $4,671,337. The Company’s liquidity needs up to the closing of the IPO on April 5, 2022 had been satisfied through proceeds from notes payable and advances from related party and from the issuance of ordinary shares. In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company with working capital. The Company’s management plans to continue its efforts to complete a Business Combination within the Combination Period after the closing of the Initial Public Offering. If our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our business combination. Moreover, we may need to obtain other financing either to complete our business combination or because we become obligated to redeem a significant number of our public shares upon consummation of our business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our business combination. If we are unable to complete our business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations. The Company has filed a preliminary proxy statement to amend its Amended and Restated Memorandum and Articles of Association, extending the deadline for consummating a business combination to January 5, 2026. The Company will have approximately 9 months to consummate a business combination as of March 31, 2025. It is uncertain that we will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution. In connection with the Company’s assessment of going concern considerations in accordance with the Accounting Standards Codification (the “ASC”) issued by Financial Accounting Standards Board (the “FASB”), in Topic 205-40, “Presentation of Financial Statements — Going Concern,” management has determined that mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance of the consolidated financial statements.

11500000

1500000

10.00

115000000

115682250

6898161

6677519

11500000

10.00

115000000

330000

10.00

3300000

5704741

2300000

2875000

529741

25000 115682250 -4671337 -4297517

1437500

25000

2875000

25000

375000

0.20

-4671337

Note 2 –Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited consolidated financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”), specifically Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the results that may be expected for the period ending December 31, 2025, or any future period. These unaudited consolidated financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto included in the Annual Report for the year ended December 31, 2024, which are included in the Form 10-K filed on March 31, 2025. Basis of Consolidation The unaudited consolidated financial statements include the accounts of the Company and its subsidiary, which was newly established on February 7, 2025. All significant intercompany accounts and transactions have been eliminated in consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company have cash held in escrow $nil as of March 31, 2025, and December 31, 2024, respectively. The Company did not have any cash equivalents as of March 31, 2025, and December 31, 2024. Marketable Securities Held in Trust Account As per ASC Topic 230, “Statement of Cash Flow” (“ASC 230”), operating cash flows include interest and dividend income receipts related to investments in other reporting entities or deposits with financial institutions (i.e., returns on investment). Interest income earned on Investments held in Trust Account is fully reinvested into the Trust Account and therefore considered as an adjustment to reconcile net profit/(loss) to net cash used in operating activities in the Statements of Cash Flows. Such interest income reinvested will be used to redeem all or a portion of the ordinary shares upon the completion of a business combination. At March 31, 2025, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. The Company’s marketable securities held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of marketable securities held in Trust Account are included in interest earned and unrealized gain on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information. The securities are presented on the balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividends, interest earned, and unrealized gain on marketable securities held in Trust Account in the accompanying statements of operations and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets for identical assets. During the three months ended March 31, 2025, other income from the Trust account amounted to $70,642 which $46,244 was reinvested in the Trust Account. $24,398 was also recognized as unrealized gain on investments held in the Trust account during the three months ended March 31, 2025. During the three ended March 31, 2024, other income from the Trust account amounted to $458,839, which $301,779 was reinvested in the Trust Account. $157,060 was also recognized as unrealized gain on investments held in the Trust account during the three months ended March 31, 2024. Deferred Offering Costs Offering costs consisted of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that directly related to the IPO. As of April 5, 2021, offering costs amounted to $5,704,741 consisting of $<span id="xdx_900_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_pp0p0_c20210405__20210405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zU0xs07KiHW8" title="Underwriting fees">2,300,000 of underwriting fees, $2,875,000 of deferred underwriting fees, and $529,741 of other offering costs. The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offering”. The Company allocates offering costs between public shares, public rights and public warrants based on the estimated fair values of public shares and public rights at the date of issuance. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the consolidated financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the consolidated financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. The Company had generated interest income from the Marketable securities held in trust that is the Unite States sources investment, which is tax exemption interest and dividends. There were no unrecognized tax benefits as of March 31, 2025, and December 31, 2024, and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. On August 16, 2022, the U.S. Government enacted legislation commonly referred to as the Inflation Reduction Act. The main provisions of the Inflation Reduction Act (the IRA) that we anticipate may impact us is a 1% excise tax on share repurchases. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Because there is possibility that the Company may acquire a U.S. domestic corporation or engage in a transaction in which a domestic corporation becomes parent or affiliate to the Company and the Company may become a “covered corporation” as a listed Company in Nasdaq. On July 13, 2023, 2,436,497 public shares were rendered for redemption in connection with an extension vote (see Note 1). The management team has evaluated the IRA as of March 31, 2025, and does not accrue any excise tax related to the redemption as the Company believes it is not a “covered corporation” under Internal Revenue Code Section 4501. The management team will continue to evaluate its impact. The provision for income taxes was deemed to be immaterial for the three months ended March 31, 2025, and March 31, 2024. Net Income (Loss) Per Share Net income (loss) per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. The calculation of diluted income (loss) per ordinary shares does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 5,915,000 shares of ordinary shares in the aggregate. As of March 31, 2025, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary shares is the same as basic net income (loss) per ordinary shares for the periods presented. The net income (loss) per share presented in the consolidated statement of operations is based on the following: Schedule of Statement of Operations <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20250101__20250331_zRyyg685GxVa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2025</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20240101__20240331_zVUpOJGEScw7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2024</td><td style="font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLoss_maNILATzPx5_z9vv55Bd0AMj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net income (loss)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(153,178</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">297,020</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RemeasurementToRedemptionValue_iN_di_msNILATzPx5_z1EfPeA5Hr01" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: remeasurement to redemption value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(150,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(150,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--InterestAndDividendsEarnedInTrustAccountToBeAllocatedToRedeemableShares_iN_di_msNILATzPx5_zxRMrJ8k5ev2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: Interest and dividends earned in Trust Account to be allocated to redeemable shares</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(70,642</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(458,839</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzPx5_zuujG4i7SDK" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Net loss excluding investment income in Trust Account</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(373,820</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(311,819</td><td style="text-align: left">)</td></tr> </table> Schedule of Net Income (Loss) Per Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="display: none"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_492_20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zmBdQSH8K6u6" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_490_20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzl1yka0h8Di" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_493_20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z0eQ9c0dxHqi" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_498_20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zjDQXhdui5Z4" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2025</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2024</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non- redeemable shares</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable shares</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non- redeemable shares</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable shares</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and Diluted net income (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Numerators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--TemporaryEquityNetIncome_zCTSc0moy9yl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Allocation of net losses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(318,858</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(54,962</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(155,972</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(155,847</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--TemporaryEquityAccretionToRedemptionValue_za2DqqM5BnNa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accretion of temporary equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--TemporaryEquityInterestInSubsidiaryEarnings_zM44HwpSauo8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accretion of temporary equity – (interest earned and unrealized gain on trust account)</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">70,642</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">458,839</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_zmp0rI97XPJg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Allocation of net income (loss)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(318,858</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">165,680</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(155,972</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">452,992</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted-average shares outstanding</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zjGNblYXHin2" title="Weighted-average shares outstanding, basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_znOTLksHFW83" title="Weighted-average shares outstanding, diluted">3,205,000</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zhwQRyI6863" title="Weighted-average shares outstanding, basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z53hE4FWL4cj" title="Weighted-average shares outstanding, diluted">552,451</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z6otaQrSZ5qh" title="Weighted-average shares outstanding, basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zBMhM8YR2twe" title="Weighted-average shares outstanding, diluted">3,205,000</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zXGAjy4sV8V5" title="Weighted-average shares outstanding, basic"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zbQ4DCIqGJwf" title="Weighted-average shares outstanding, diluted">3,202,416</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic and diluted net income (loss) per share</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.10</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.30</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.14</td><td style="text-align: left"> </td></tr> </table> Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s consolidated financial statements. Warrants The Company evaluates the Public and Private Warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in FASB ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both Public and Private Warrants issued were classified in shareholders’ equity. Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares is classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption is presented at redemption value (plus any interest earned on the Trust Account) as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Basis of Presentation The accompanying unaudited consolidated financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”), specifically Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the results that may be expected for the period ending December 31, 2025, or any future period. These unaudited consolidated financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto included in the Annual Report for the year ended December 31, 2024, which are included in the Form 10-K filed on March 31, 2025.

Basis of Consolidation The unaudited consolidated financial statements include the accounts of the Company and its subsidiary, which was newly established on February 7, 2025. All significant intercompany accounts and transactions have been eliminated in consolidation.

Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company have cash held in escrow $nil as of March 31, 2025, and December 31, 2024, respectively. The Company did not have any cash equivalents as of March 31, 2025, and December 31, 2024.

Marketable Securities Held in Trust Account As per ASC Topic 230, “Statement of Cash Flow” (“ASC 230”), operating cash flows include interest and dividend income receipts related to investments in other reporting entities or deposits with financial institutions (i.e., returns on investment). Interest income earned on Investments held in Trust Account is fully reinvested into the Trust Account and therefore considered as an adjustment to reconcile net profit/(loss) to net cash used in operating activities in the Statements of Cash Flows. Such interest income reinvested will be used to redeem all or a portion of the ordinary shares upon the completion of a business combination. At March 31, 2025, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. The Company’s marketable securities held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of marketable securities held in Trust Account are included in interest earned and unrealized gain on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information. The securities are presented on the balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividends, interest earned, and unrealized gain on marketable securities held in Trust Account in the accompanying statements of operations and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets for identical assets. During the three months ended March 31, 2025, other income from the Trust account amounted to $70,642 which $46,244 was reinvested in the Trust Account. $24,398 was also recognized as unrealized gain on investments held in the Trust account during the three months ended March 31, 2025. During the three ended March 31, 2024, other income from the Trust account amounted to $458,839, which $301,779 was reinvested in the Trust Account. $157,060 was also recognized as unrealized gain on investments held in the Trust account during the three months ended March 31, 2024.

70642

46244

24398

458839

301779

157060

Deferred Offering Costs Offering costs consisted of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that directly related to the IPO. As of April 5, 2021, offering costs amounted to $5,704,741 consisting of $<span id="xdx_900_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_pp0p0_c20210405__20210405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zU0xs07KiHW8" title="Underwriting fees">2,300,000 of underwriting fees, $2,875,000 of deferred underwriting fees, and $529,741 of other offering costs. The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offering”. The Company allocates offering costs between public shares, public rights and public warrants based on the estimated fair values of public shares and public rights at the date of issuance.

5704741

2300000

2875000

529741

Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the consolidated financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the consolidated financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. The Company had generated interest income from the Marketable securities held in trust that is the Unite States sources investment, which is tax exemption interest and dividends. There were no unrecognized tax benefits as of March 31, 2025, and December 31, 2024, and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. On August 16, 2022, the U.S. Government enacted legislation commonly referred to as the Inflation Reduction Act. The main provisions of the Inflation Reduction Act (the IRA) that we anticipate may impact us is a 1% excise tax on share repurchases. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Because there is possibility that the Company may acquire a U.S. domestic corporation or engage in a transaction in which a domestic corporation becomes parent or affiliate to the Company and the Company may become a “covered corporation” as a listed Company in Nasdaq. On July 13, 2023, 2,436,497 public shares were rendered for redemption in connection with an extension vote (see Note 1). The management team has evaluated the IRA as of March 31, 2025, and does not accrue any excise tax related to the redemption as the Company believes it is not a “covered corporation” under Internal Revenue Code Section 4501. The management team will continue to evaluate its impact. The provision for income taxes was deemed to be immaterial for the three months ended March 31, 2025, and March 31, 2024.

0.01

2436497

Net Income (Loss) Per Share Net income (loss) per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. The calculation of diluted income (loss) per ordinary shares does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 5,915,000 shares of ordinary shares in the aggregate. As of March 31, 2025, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary shares is the same as basic net income (loss) per ordinary shares for the periods presented. The net income (loss) per share presented in the consolidated statement of operations is based on the following: Schedule of Statement of Operations <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20250101__20250331_zRyyg685GxVa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2025</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20240101__20240331_zVUpOJGEScw7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2024</td><td style="font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLoss_maNILATzPx5_z9vv55Bd0AMj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net income (loss)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(153,178</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">297,020</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RemeasurementToRedemptionValue_iN_di_msNILATzPx5_z1EfPeA5Hr01" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: remeasurement to redemption value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(150,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(150,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--InterestAndDividendsEarnedInTrustAccountToBeAllocatedToRedeemableShares_iN_di_msNILATzPx5_zxRMrJ8k5ev2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: Interest and dividends earned in Trust Account to be allocated to redeemable shares</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(70,642</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(458,839</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzPx5_zuujG4i7SDK" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Net loss excluding investment income in Trust Account</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(373,820</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(311,819</td><td style="text-align: left">)</td></tr> </table> Schedule of Net Income (Loss) Per Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="display: none"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_492_20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zmBdQSH8K6u6" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_490_20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzl1yka0h8Di" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_493_20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z0eQ9c0dxHqi" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_498_20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zjDQXhdui5Z4" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2025</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2024</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non- redeemable shares</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable shares</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non- redeemable shares</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable shares</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and Diluted net income (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Numerators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--TemporaryEquityNetIncome_zCTSc0moy9yl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Allocation of net losses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(318,858</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(54,962</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(155,972</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(155,847</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--TemporaryEquityAccretionToRedemptionValue_za2DqqM5BnNa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accretion of temporary equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--TemporaryEquityInterestInSubsidiaryEarnings_zM44HwpSauo8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accretion of temporary equity – (interest earned and unrealized gain on trust account)</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">70,642</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">458,839</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_zmp0rI97XPJg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Allocation of net income (loss)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(318,858</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">165,680</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(155,972</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">452,992</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted-average shares outstanding</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zjGNblYXHin2" title="Weighted-average shares outstanding, basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_znOTLksHFW83" title="Weighted-average shares outstanding, diluted">3,205,000</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zhwQRyI6863" title="Weighted-average shares outstanding, basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z53hE4FWL4cj" title="Weighted-average shares outstanding, diluted">552,451</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z6otaQrSZ5qh" title="Weighted-average shares outstanding, basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zBMhM8YR2twe" title="Weighted-average shares outstanding, diluted">3,205,000</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zXGAjy4sV8V5" title="Weighted-average shares outstanding, basic"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zbQ4DCIqGJwf" title="Weighted-average shares outstanding, diluted">3,202,416</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic and diluted net income (loss) per share</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.10</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.30</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.14</td><td style="text-align: left"> </td></tr> </table>

5915000

The net income (loss) per share presented in the consolidated statement of operations is based on the following: Schedule of Statement of Operations <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20250101__20250331_zRyyg685GxVa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2025</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20240101__20240331_zVUpOJGEScw7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2024</td><td style="font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLoss_maNILATzPx5_z9vv55Bd0AMj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net income (loss)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(153,178</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">297,020</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--RemeasurementToRedemptionValue_iN_di_msNILATzPx5_z1EfPeA5Hr01" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: remeasurement to redemption value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(150,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(150,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--InterestAndDividendsEarnedInTrustAccountToBeAllocatedToRedeemableShares_iN_di_msNILATzPx5_zxRMrJ8k5ev2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: Interest and dividends earned in Trust Account to be allocated to redeemable shares</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(70,642</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(458,839</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzPx5_zuujG4i7SDK" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Net loss excluding investment income in Trust Account</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(373,820</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(311,819</td><td style="text-align: left">)</td></tr> </table>

-153178

297020

150000 150000 70642 458839

-373820

-311819

Schedule of Net Income (Loss) Per Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="display: none"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_492_20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zmBdQSH8K6u6" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_490_20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zzl1yka0h8Di" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_493_20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z0eQ9c0dxHqi" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_498_20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zjDQXhdui5Z4" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2025</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2024</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non- redeemable shares</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable shares</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non- redeemable shares</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable shares</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and Diluted net income (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Numerators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--TemporaryEquityNetIncome_zCTSc0moy9yl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Allocation of net losses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(318,858</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(54,962</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(155,972</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(155,847</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--TemporaryEquityAccretionToRedemptionValue_za2DqqM5BnNa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accretion of temporary equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--TemporaryEquityInterestInSubsidiaryEarnings_zM44HwpSauo8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accretion of temporary equity – (interest earned and unrealized gain on trust account)</td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">70,642</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">458,839</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_zmp0rI97XPJg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Allocation of net income (loss)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(318,858</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">165,680</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(155,972</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">452,992</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominators:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted-average shares outstanding</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zjGNblYXHin2" title="Weighted-average shares outstanding, basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_znOTLksHFW83" title="Weighted-average shares outstanding, diluted">3,205,000</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zhwQRyI6863" title="Weighted-average shares outstanding, basic"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_z53hE4FWL4cj" title="Weighted-average shares outstanding, diluted">552,451</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z6otaQrSZ5qh" title="Weighted-average shares outstanding, basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zBMhM8YR2twe" title="Weighted-average shares outstanding, diluted">3,205,000</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zXGAjy4sV8V5" title="Weighted-average shares outstanding, basic"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240331__us-gaap--StatementClassOfStockAxis__custom--RedeemableSharesMember_zbQ4DCIqGJwf" title="Weighted-average shares outstanding, diluted">3,202,416</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic and diluted net income (loss) per share</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.10</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.30</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.05</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.14</td><td style="text-align: left"> </td></tr> </table>

-318858

-54962

-155972

-155847

150000

70642

458839

-318858

165680

-155972

452992

3205000

552451

3205000

3202416

-0.10

0.30

-0.05

0.14

Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

Warrants The Company evaluates the Public and Private Warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in FASB ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both Public and Private Warrants issued were classified in shareholders’ equity. Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares is classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption is presented at redemption value (plus any interest earned on the Trust Account) as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Note 3 – Initial Public Offering On April 5, 2022, the Company sold 11,500,000 Units (including the issuance of <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zl1gKMLdQ1ah" title="Number of shares issued">1,500,000 Units as a result of the underwriter’s fully exercise of the over-allotment) at a price of $10.00 per Unit, generating gross proceeds of $115,000,000 related to the IPO. Each Unit consists of one ordinary share, one redeemable warrant (each a “Warrant”, and, collectively, the “Warrants”), and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an Initial Business Combination. Each redeemable warrant entitles the holder thereof to purchase one ordinary share, and each ten rights entitles the holder thereof to receive one ordinary share at the closing of a Business Combination. No fractional shares issued upon separation of the Units, and only whole Warrants will trade. The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to an additional <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zqXFgqzgllF1" title="Number of shares issued">1,500,000 Public Units to cover over-allotments. On April 5, 2022, the underwriter exercised the over-allotment option in full to purchase <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zg0azdk0LPhf" title="Number of shares issued">1,500,000 Public Units, at a purchase price of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zKaawUrpt9N3" title="Price per share">10.00 per Public Unit, generating gross proceeds to the Company of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UnderwritersMember_zV63hFXt7z66" title="Gross proceeds">15,000,000 (see Note 7). On January 26, 2023, an Extraordinary General Meeting of shareholders was held to approve the proposal to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination twelve (12) times for an additional one (1) month each time from February 5, 2023 to February 5, 2024. In connection with the Extraordinary General Meeting, a total of 5,885,324 ordinary shares were presented for redemption in connection with the Extraordinary General Meeting. On October 30, 2023, an Extraordinary General Meeting of shareholders was held to approve the proposal to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination six (6) times for an additional one (1) month each time from February 5, 2024 to August 5, 2024. To effectuate each monthly extension, the Company and/or its Sponsor will deposit the lesser of (i) $50,000 for all remaining public shares and (ii) $0.033 for each remaining public share into the Trust Account. In connection with the Extraordinary General Meeting, a total of 2,412,260 ordinary shares were presented for redemption in connection with the Extraordinary General Meeting. On August 6, 2024, the Company filed the preliminary proxy statements to SEC, which had proposed to amend the memorandum and articles of association of the Company to extend the date of consummate a business combination to April 5, 2025. On March 17, 2025, the Company filed a definitive proxy statement with the SEC in connection with calling on an Extraordinary General Meeting to be held on April 2, 2025, which had proposed to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination from April 5, 2025 to January 5, 2026. At March 31, 2025, the ordinary shares reflected in the balance sheet are reconciled in the following tables: Schedule of Ordinary Share Reflected in Balance Sheet <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_49C_20250101__20250331_zY4caB4Z6BM5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_400_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_maOSSTPzNc6_zeRnuKgHjsjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 84%; text-align: justify">Gross proceeds from public shares</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right">115,000,000</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less:</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_ecustom--ProceedsAllocatedToPublicRights_iN_di_msOSSTPzNc6_z660Y4D3gOKd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Proceeds allocated to public rights</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(8,510,000</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr id="xdx_407_eus-gaap--ProceedsFromIssuanceOfWarrants_iN_di_msOSSTPzNc6_z0Kbj2dJJjmg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Proceeds allocated to public warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,290,000</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr id="xdx_408_ecustom--AllocationOfOfferingCostsRelatedToOrdinaryShares_iN_di_msOSSTPzNc6_zAAaLPDHwfjh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Allocation of offering costs related to ordinary shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,020,172</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr id="xdx_40A_eus-gaap--PaymentsForRepurchaseOfInitialPublicOffering_iN_di_msOSSTPzNc6_zxk7armdvYLc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Redemption of Public Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(117,440,382</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Plus:</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40D_eus-gaap--TemporaryEquityAccretionToRedemptionValue_zDl7cQj93nq5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Accretion of carrying value to redemption value</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21,737,903</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_406_ecustom--SubsequentMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_maOSSTPzNc6_zvn5X8nCXhs8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Subsequent measurement of Class A ordinary shares subject to possible redemption (interest earned and unrealized gains on trust account)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,420,812</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Ordinary shares subject to possible redemption (plus any interest earned on the Trust Account)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20250331_zJTb6SS070of" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption (plus any interest earned on the Trust Account)">6,898,161</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table>

11500000

1500000

10.00

115000000

1500000

10.00

15000000

5885324

50000

0.033

2412260

At March 31, 2025, the ordinary shares reflected in the balance sheet are reconciled in the following tables: Schedule of Ordinary Share Reflected in Balance Sheet <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_49C_20250101__20250331_zY4caB4Z6BM5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_400_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_maOSSTPzNc6_zeRnuKgHjsjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 84%; text-align: justify">Gross proceeds from public shares</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right">115,000,000</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less:</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_ecustom--ProceedsAllocatedToPublicRights_iN_di_msOSSTPzNc6_z660Y4D3gOKd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Proceeds allocated to public rights</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(8,510,000</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr id="xdx_407_eus-gaap--ProceedsFromIssuanceOfWarrants_iN_di_msOSSTPzNc6_z0Kbj2dJJjmg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Proceeds allocated to public warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,290,000</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr id="xdx_408_ecustom--AllocationOfOfferingCostsRelatedToOrdinaryShares_iN_di_msOSSTPzNc6_zAAaLPDHwfjh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Allocation of offering costs related to ordinary shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,020,172</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr id="xdx_40A_eus-gaap--PaymentsForRepurchaseOfInitialPublicOffering_iN_di_msOSSTPzNc6_zxk7armdvYLc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Redemption of Public Shares</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(117,440,382</td> <td style="font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Plus:</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40D_eus-gaap--TemporaryEquityAccretionToRedemptionValue_zDl7cQj93nq5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Accretion of carrying value to redemption value</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21,737,903</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_406_ecustom--SubsequentMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemptionInterestEarnedOnTrustAccount_maOSSTPzNc6_zvn5X8nCXhs8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Subsequent measurement of Class A ordinary shares subject to possible redemption (interest earned and unrealized gains on trust account)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 6,420,812</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Ordinary shares subject to possible redemption (plus any interest earned on the Trust Account)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_985_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20250331_zJTb6SS070of" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ordinary shares subject to possible redemption (plus any interest earned on the Trust Account)">6,898,161</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table>

115000000

8510000

5290000

5020172

117440382

21737903

6420812

6898161

Note 4 – Private Placement The Sponsor has committed to purchase an aggregate of <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z7lLkYLpHhrk" title="Number of shares issued">300,000 Placement Units (or <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zKIBICLrbIRf" title="Number of shares issued">330,000 Placement Units if the underwriters’ over-allotment is exercised in full) at a price of $10.00 per Placement Unit, ($<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_znkkeylpAja2" title="Proceeds from issuance of private placement">3,000,000 in the aggregate, or $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220405__20220405__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z7brDPliI2dd" title="Proceeds from issuance of private placement">3,300,000 in the aggregate if the underwriters’ over-allotment is exercised in full), from the Company in a private placement that will occur simultaneously with the closing of the IPO (the “Private Placement”). On April 5, 2022, simultaneously with the consummation of the IPO transaction, the Company received Private Placement funds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220405__20220405__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zjXvogejnKcc" title="Proceeds from issuance of private placement">3,300,000 from the Sponsor and consummated the Private Placement transaction. The private units are identical to the Public Units sold in the IPO.

300000

330000

10.00

3000000

3300000

Note 5 – Related Party Transactions Founder Shares In May 2021, Harneys Fiduciary (Cayman) Limited transferred one ordinary share to the Sponsor for par value. On July 5, 2021 the Company redeemed the one share for par value and the Sponsor purchased <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210705__20210705__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zrfKvDriY93" title="Stock issued during period, shares">1,437,500 ordinary shares for an aggregate price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210705__20210705__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zRXREL7Jr4i8" title="Stock issued during period, value">25,000. The <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210705__20210705__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zVCb6RHeDSYe" title="Stock issued during period, shares">1,437,500 founder shares (for purposes hereof referred to as the “Founder Shares”) include an aggregate of up to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210705__20210705__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--RangeAxis__srt--MaximumMember_zZmZHQdksxf" title="Ordinary shares subject to forfeiture">187,500 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210705__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z0u7KkRAtgW7" title="Ownership percentage">20% of the Company’s issued and outstanding shares after the IPO. In September 2021, the Company repurchased <span id="xdx_90F_eus-gaap--StockRepurchasedDuringPeriodShares_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zl0VEpDhjph7" title="Stock repurchased during period, shares">1,437,500 of founder shares for $<span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodValue_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zq9oeZHMXGg1" title="Stock repurchased during period, value">25,000. In September 2021, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zuMFN0WUKkAf" title="Stock issued during period, shares">2,875,000 of founder shares for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zKbLMx53WBwl" title="Stock issued during period, value">25,000 which include an aggregate of up to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210901__20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--RangeAxis__srt--MaximumMember_zY8tGF0Tjsj6" title="Ordinary shares subject to forfeiture">375,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zV4qfmpGQE7" title="Ownership percentage">20% of the Company’s issued and outstanding shares after the IPO. On April 5, 2022, the underwriter exercised its over-allotment option, as a result, no Founder Shares are subject to forfeiture. Administrative Services Agreement The Company entered into an administrative services agreement, commencing on April 5, 2022, through the earlier of the Company’s consummation of a Business Combination or its liquidation, to pay to the Sponsor a total of $<span id="xdx_906_eus-gaap--OtherReceivablesNetCurrent_iI_c20220405__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--TypeOfArrangementAxis__custom--AdministrativeServicesAgreementMember_z86hQWHe95re" title="Other receivables, net, current">10,000 per month for office space, secretarial and administrative services provided to members of the Company’s management team. For three months ended March 31, 2025, and 2024, the Company incurred $<span id="xdx_90A_eus-gaap--PaymentForAdministrativeFees_c20250101__20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--TypeOfArrangementAxis__custom--AdministrativeServicesAgreementMember_zLX74cTv1uk3" title="Payment for administrative fees">30,000 and $<span id="xdx_906_eus-gaap--PaymentForAdministrativeFees_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--TypeOfArrangementAxis__custom--AdministrativeServicesAgreementMember_z9nNMwM6JSv7" title="Payment for administrative fees">30,000 in fees for these services. As of March 31, 2025, and December 31, 2024, the total balance of unpaid fees with amounts of $<span id="xdx_90F_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--TypeOfArrangementAxis__custom--AdministrativeServicesAgreementMember_znltWKMtun15" title="Accrual expenses">358,333 and $<span id="xdx_909_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--TypeOfArrangementAxis__custom--AdministrativeServicesAgreementMember_zghNdEGVnRde" title="Accrual expenses">328,333 included in accrued expenses. Promissory Note — Related Party On June 15, 2021, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20210615__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SponsorMember_znsuirBxmZOa" title="Debt instrument, principal amount">300,000 (the “Pre-IPO Promissory Note”). On December 15, 2021, Company amended the Pre-IPO Promissory Note to extend the due date. The Pre-IPO Promissory Note is non-interest bearing and payable on the earlier of (i) March 31, 2022 or (ii) the consummation of the IPO, which was paid off as of April 5, 2022. On January 3, 2023, the Company issued a promissory note in the principal amount of up to $1,000,000 (the “Promissory Note”) to M-Star Management Corp. Pursuant to which the Sponsor shall loan to the Company up to $1,000,000 to pay the extension fee and transaction cost. The Notes bear no interest and are repayable in full upon the earlier of (a) December 31, 2023 or (b) the date of the consummation of the Company’s initial business combination. The issuance of the Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. On April 18, 2023, the Company amended and restated Promissory Note (the “First Amended Promissory Note”) in order to increase the available principal amount from $1,000,000 to $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230418__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MStarManagementCorpMember__srt--RangeAxis__srt--MaximumMember_zh3dxzjseede" title="Principal amount">2,500,000, and b) change the repayment term as repayable in full upon the date of the consummation of the Company’s initial business combination. On December 22, 2023, the Company amended and restated Promissory Note (the “Second Amended Promissory Note”) in order to increase the available principal amount from $2,500,000 up to $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20231222__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MStarManagementCorpMember__srt--RangeAxis__srt--MaximumMember_zFcEoBodu1w7" title="Principal amount">3,000,000. On January 4, 2023, the Company started to draw the funds and deposited it into the trust account to extend the period of time the Company has to consummate a business combination by one month to February 5, 2023. The $383,333 extension fee represents approximately $0.033 per public share. Starting in February 2023, the extension fee changed to $187,155 because 5,885,324 public shares were redeemed. Starting in November 2023, the extension fee changed to the lower of $50,000 or $105,680 ($0.033 per share) because 2,412,260 public shares were redeemed. As of March 31, 2025, and December 31, 2024, the loans under the promissory notes were $2,972,403 and $2,822,403. Due to Related Party As of March 31, 2025, and December 31, 2024, the Company has amounts due to the Sponsor of $1,310,823 and $1,081,153 for formation and operational costs paid by the Sponsor on behalf of the Company. The amounts are due on demand, non-interest bearing and not considered to be drawdowns on the Amended Promissory Note.

1437500

25000

1437500

187500

0.20

1437500

25000

2875000

25000

375000

0.20

10000

30000

358333

328333

300000

1000000

2500000

3000000

383333

0.033

187155

5885324

50000 105680

0.033

2412260

2972403

2822403

1310823

1081153

Note 6 – Commitments and Contingencies Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. In the beginning of February 2022, the Russian Federation and Belarus commenced a military action against the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The impact of this action and related sanctions on the world economy are not determinable as of the date of these consolidated financial statements. Registration Rights The holders of the Founder Shares will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the IPO. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement On August 10, 2021, the Company engaged Ladenburg Thalmann & Co. Inc. as its underwriter. The Company will granted the underwriters a 45-day option to purchase up to <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210810__20210810__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgThalmannMember__srt--RangeAxis__srt--MaximumMember_z1CnZSGJPwdi" title="Sale of units in initial public offering">1,500,000 additional Units to cover over-allotments at the IPO price, less the underwriting discounts and commissions. Ladenburg Thalmann has agreed to revise the warrant agreement that the warrant is exercisable on the later of one year after the closing of this offering or the consummation of an initial business combination. The underwriters were entitled to a cash underwriting discount of: (i) two percent (<span id="xdx_90E_ecustom--PercentageOfCashUnderwritingCommission_pid_dp_uPure_c20250101__20250331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zniF3bes4utf" title="Percentage of cash underwriting commission">2.0%) of the gross proceeds of the IPO, or $2,300,000 with the underwriters’ over-allotment is exercised in full. In addition, the underwriters are entitled to a deferred fee of two and one half percent (<span id="xdx_904_ecustom--PercentageOfUnderwritersDeferredFee_pid_dp_uPure_c20250101__20250331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zcZG27ZNf6O9" title="Percentage of underwrier deferred fee">2.50%) of the gross proceeds of the IPO, or $2,875,000 with the underwriters’ over- allotment is exercised in full upon closing of the Business Combination. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement. As of March 31, 2025, and December 31, 2024, the Company have deferred underwriting commissions of $2,875,000 as non-current liabilities, respectively. Professional Fees The Company has paid professional fees of $25,000 upon initial filing with the SEC of the registration statement for the public offering, and $150,000 at the closing of the public offering as of April 5, 2022. The Company entered into the agreement with a retainer of $5,000 per month starting from April 1, 2022. The Company dismissed the prior legal counsel in February 2024 and engaged the new legal counsel with $2,500 per month for SEC compliance from February 2024 to November 2024. The Company dismissed the new legal counsel in November 2024 and engaged with another legal counsel with a quarterly fee of $13,750 for SEC compliance. For the years ended as of March 31, 2025 and 2024, the Company incurred $13,750 and $10,000 in fees for these services, respectively. Contingencies and Dismissal of the Then-Legal Counsel The Company may from time to time be subject to various legal or administrative claims and proceedings arising in the ordinary course of business. As of March 31, 2025, and December 31, 2024, there were no legal or administrative proceedings for which a loss was probable and expected to be material to the consolidated financial statements. On February 5, 2024, management and the Sponsor decided to dismiss the Company’s then-legal counsel and terminated its services of maintaining and managing the escrow account. During the year ended December 31, 2023, the Company received invoices with the total amounts of $155,000 for services related to the Merger Agreement and Initial Business Combination from the then-legal counsel. All received invoices were paid until the termination of services, which coincides with the termination of Merger Agreement. The Company did not have an executed engagement letter with the then-legal counsel. Management estimates the maximum service fees for the Initial Business Combination would be $400,000 based on other executed service agreements with the same then-legal counsel. We believe that we have a potential liability of $245,000 for potential unbilled service fees resulting from the termination of Merger Agreement, which represents a loss contingency to the Company. As of March 31, 2025, the Company has not recorded the potential amounts in the consolidated financial statements, as management does not believe it is more likely than not that we will be invoiced for additional services.

1500000

0.020 2300000 0.0250 2875000 2875000 2875000 25000

150000

The Company entered into the agreement with a retainer of $5,000 per month starting from April 1, 2022.

2500

13750

10000

155000

400000

245000

Note 7 – Shareholders’ Deficit Ordinary Shares The Company is authorized to issue 50,000,000 ordinary shares, with a par value of $0.001 per share. Holders of the ordinary shares are entitled to one vote for each ordinary share. At April 5, 2022, there was 3,205,000 ordinary shares issued and outstanding, excluding 11,500,000 ordinary shares subject to possible redemption. The Sponsor has agreed to forfeit <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20250101__20250331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zooIjuGQugLk" title="Ordinary shares subject to forfeiture">375,000 ordinary shares to the extent that the over-allotment option is not exercised in full by the underwriter. On April 5, 2022, the underwriter fully exercised the over-allotment option, as such there are no ordinary shares subject to forfeiture. Warrants Each warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share commencing 30 days after the completion of its initial business combination and expiring five years from after the completion of an initial business combination. No fractional warrant will be issued and only whole warrants will trade. The Company may redeem the warrants at a price of $<span id="xdx_907_ecustom--ClassOfWarrantsOrRightsRedemptionPricePerShare_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zDW6hq0BpIs8" title="Class of warrants or rights redemption price per share">0.01 per warrant upon 30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $18.00 per share for any <span id="xdx_90D_ecustom--NumberOfTradingDaysForDeterminingTheVolumeWeightedAveragePriceOfShare_dtD_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zEpERhVCEQS5" title="Number of consecutive trading days for determining the volume weighted average price of share">20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given, provided there is an effective registration statement and current prospectus in effect with respect to the ordinary shares underlying such warrants during the 30 day redemption period. If a registration statement is not effective within <span id="xdx_908_ecustom--ClassOfWarrantsOrRightsPeriodWithinWhichTheRegistrationShallBeEffectiveFromTheConsummationOfBusinessCombination_dtD_c20250101__20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_ztbhcdRprjSd" title="Class of warrants or rights period within the registration shall be effective from the consummation of business combination">60 days following the consummation of a business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. In addition, if (a) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $<span id="xdx_903_eus-gaap--BusinessAcquisitionSharePrice_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__us-gaap--SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_zYlL8iQud039" title="Business combination effective issue price">9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors), (b) the aggregate gross proceeds from such issuances represent more than <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--InitialBusinessCombinationMember_zySh1PShE879" title="Total equity investment percentage">60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination, and (c) the volume weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $<span id="xdx_90D_eus-gaap--BusinessAcquisitionSharePrice_iI_c20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__us-gaap--SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_zhBCDQAYhiw9" title="Business combination effective issue price">9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to <span id="xdx_90D_ecustom--ClassOfWarrantsOrRightsExercisePricePercentage_iI_pid_dp_uPure_c20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zoGhDyYDX2j1" title="Class of warrants or rights exercise price percentage">115% of the Market Value, and the last sales price of the ordinary shares that triggers the Company’s right to redeem the Warrants will be adjusted (to the nearest cent) to be equal to <span id="xdx_903_ecustom--ClassOfWarrantsOrRightsExercisePriceOfMarketValuePercentage_iI_pid_dp_uPure_c20250331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zwwBYbiNWO6b" title="Class of warrants or rights exercise price market value percentage">180% of the Market Value.

50000000

0.001

3205000

11500000

375000

11.50

0.01

18.00

P20D P60D

9.20

0.60

9.20

1.15 1.80

Note 8 – Fair Value Measurements The Company complies with ASC 820, “Fair Value Measurements”, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. ASC 820 determines fair value to be the price that would be received to sell an asset or would be paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.65in; text-align: justify">Level 1:</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Level 2:</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Level 3:</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</td></tr> </table> At March 31, 2025, the assets held in the trust account were entirely comprised of marketable securities, with all investments fully allocated to money market funds securities. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2025, and December 31, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. Schedule of Assets Measured at Fair Value on a Recurring Basis March 31, 2025 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Assets</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Quoted Prices in Active Markets (Level 1)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Significant Other Unobservable Inputs (Level 3)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify">Marketable Securities held in Trust Account</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecurities_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zY1faIDIGnhi" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">6,898,161</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--MarketableSecurities_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z8TTtMEmqmU4" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecurities_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zWjbCXLlYoMf" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">-</td><td style="width: 1%; text-align: left"> </td></tr> </table> December 31, 2024 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Assets</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Quoted Prices in Active Markets (Level 1)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Significant Other Unobservable Inputs (Level 3)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify">Marketable Securities held in Trust Account</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--MarketableSecurities_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zT8vF9rdMlu6" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">6,677,519</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--MarketableSecurities_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxWSAdSCvMQl" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--MarketableSecurities_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlxBwmkenD44" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">-</td><td style="width: 1%; text-align: left"> </td></tr> </table>

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2025, and December 31, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. Schedule of Assets Measured at Fair Value on a Recurring Basis March 31, 2025 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Assets</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Quoted Prices in Active Markets (Level 1)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Significant Other Unobservable Inputs (Level 3)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify">Marketable Securities held in Trust Account</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecurities_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zY1faIDIGnhi" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">6,898,161</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--MarketableSecurities_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z8TTtMEmqmU4" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecurities_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zWjbCXLlYoMf" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">-</td><td style="width: 1%; text-align: left"> </td></tr> </table> December 31, 2024 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Assets</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Quoted Prices in Active Markets (Level 1)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Significant Other Unobservable Inputs (Level 3)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify">Marketable Securities held in Trust Account</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--MarketableSecurities_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zT8vF9rdMlu6" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">6,677,519</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--MarketableSecurities_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxWSAdSCvMQl" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--MarketableSecurities_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlxBwmkenD44" style="width: 14%; text-align: right" title="Marketable Securities held in Trust Account">-</td><td style="width: 1%; text-align: left"> </td></tr> </table>

6898161

6677519

Note 9 – Subsequent Events In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred up to the date of the consolidated financial statements were available to issue. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements except the following: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 2, 2025, Metal Sky Star Acquisition Corporation, a Cayman Islands exempted company (“Metal Sky Star” or the “Company”), received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that (i) the Staff has determined that the Company’s securities will be delisted from The Nasdaq Stock Market; (ii) trading of the Company’s Ordinary Shares, Units, Rights, and Warrants will be suspended at the opening of business on April 9, 2025; and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market. Pursuant to Nasdaq Listing Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company failed to complete its initial business combination by March 31, 2025, the Company did not comply with IM-5101-2, and its securities are now subject to delisting. The Company will not appeal Nasdaq’s determination to delist the Company’s securities and accordingly, the Company’s securities were suspended from trading on Nasdaq at the opening of business on April 9, 2025. The Company intends to apply for the listing of its securities on the OTC market under the same ticker symbols after they are delisted from Nasdaq. The Company is working diligently to complete a business combination as soon as practicable. The Company will remain a reporting entity under the Securities Exchange Act of 1934, as amended, with respect to continued disclosure of financial and operational information. Amendments to Articles of Incorporation On April 2, 2025, Metal Sky Star held an Extraordinary General Meeting of its shareholders. At the Extraordinary General Meeting, the shareholders approved certain amendments to Metal Sky Star’s amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”). The proposed amendments to the Company’s Amended and Restated Memorandum and Articles of Association approved by the Company’s shareholders were to (a) extend the date by which the Company has to consummate a business combination up to nine (9) times from April 5, 2025 to January 5, 2026, (b) reduce the amount of the fee to extend such time period into $25,000 for each one-month extension and (c) eliminate (i) the limitation that the Company shall not redeem its public shares to the extent that such redemption would result in the ordinary shares, or the securities of any entity that succeeds the Company as a public company, becoming “penny stock” (as defined in accordance with Rule 3a51-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), or cause the Company to not meet any greater net tangible asset or cash requirement which may be contained in the agreement relating to a business combination (the “Redemption Limitation”) and (ii) the limitation that the Company shall not consummate a business combination if the Redemption Limitation is exceeded. Expenses Sponsor paid on behalf of the Company Subsequent to March 31, 2025, the Sponsor paid a total of $<span id="xdx_90F_eus-gaap--OtherCostAndExpenseOperating_c20250401__20250430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zSfLwQ60Gcfi" title="Operating expenses paid by sponsor">78,604 operating expenses on behalf of the Company. The payment by the Sponsor was not considered as a drawdown of the Amended Promissory Notes. As of the date of filing, the total amount due to Sponsor was $<span id="xdx_90E_eus-gaap--OtherLiabilitiesCurrent_iI_c20250430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z5OH0k9jziPc" title="Amount due to sponsor">1,386,461.

25000

78604

1386461